Back to the full story1 source · STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials◆ All Sources
STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials
1 region · 1 outlet · 1 report — every source grouped by where each outlet is based. Region reflects only headquarters, not the subject of the report.
Other
1 article · 1 outlet